CasLoc logo
All Cases PTAB Litigations UPC Oppositions

GLYCOBIOSCIENCES, INC. v. INNOCUTIS HOLDINGS, LLC

1:12-cv-01901

Overview

Case Number 1:12-cv-01901
Filing Date 2012-11-25
Status Terminated
Termination Date 2016-12-22
Court District Court, District of Columbia (dcd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

FIDIA FARMACEUTICI S.P.A. NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Quentin Rick Corrie

BIRCH STEWART KOLASCH & BIRCH, LLP

Tel: +1 (703) 205-8032
Fax: +1 (703) 205-8050

8110 Gatehouse Road, Suite 100 East

INNOCUTIS HOLDING LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Claimant

FIDIA FARMACEUTICI S.P.A. NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Quentin Rick Corrie

BIRCH STEWART KOLASCH & BIRCH, LLP

Tel: +1 (703) 205-8032
Fax: +1 (703) 205-8050

8110 Gatehouse Road, Suite 100 East

INNOCUTIS HOLDINGS, LLC. NPE (Patent Assertion Entity)

Represented By

3 Attorneys Listed

Quentin Rick Corrie

BIRCH STEWART KOLASCH & BIRCH, LLP

Tel: +1 (703) 205-8032
Fax: +1 (703) 205-8050

8110 Gatehouse Road, Suite 100 East

DARA BIOSCIENCES, INC. Operating Company

Represented By

3 Attorneys Listed

Quentin Rick Corrie

BIRCH STEWART KOLASCH & BIRCH, LLP

Tel: +1 (703) 205-8032
Fax: +1 (703) 205-8050

8110 Gatehouse Road, Suite 100 East

Counter Defendant

GLYCOBIOSCIENCES, INC. Operating Company

Represented By

4 Attorneys Listed

Court & Judges

Court

District Court, District of Columbia (dcd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): 🇨🇦 Canada 🇩🇪 Germany 🇪🇺 Europe 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US4767463
Glycosaminoglycan and cationic polymer combinations
Filed: 1987-04-15
Issued: 1988-08-30
Expired (Term Ended)
Expires: 2007-04-15
US4240450
Composition and process for the treatment of keratin materials with polymers
Filed: 1978-03-14
Issued: 1980-12-23
Expired (Term Ended)
Expires: 1998-03-14
US6335034
Topical drug preparations
Filed: 2000-03-29
Issued: 2002-01-01
Expired (Term Ended)
Expires: 2020-03-29
US6120804
Topical drug preparations
Filed: 1999-04-08
Issued: 2000-09-19
Expired (Term Ended)
Expires: 2019-04-08
US6723345
Topical drug preparations
Filed: 2001-11-07
Issued: 2004-04-20
Expired (Term Ended)
Expires: 2021-11-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

98

Dispositive

38

Granted

1

Denied

0

Pending / Review

71

Motions by Category

Motion to Dismiss 14 Motion to Stay 5 Procedural / Extension Motion 37 Motion to Strike / Sanctions 4 Claim Construction / Markman Filing 12 Motion to Compel Discovery 2 Motion to Dismiss (FRCP 12(b)(6)) 6 Motion for Summary Judgment (Rule 56) 7 Motion to Stay Pending IPR / Reexam 11

Key Dispositive Motions & Rulings

Motion to Dismiss Granted in Part
MEMORANDUM AND OPINION: It is hereby ORDERED that Fidias motion to dismiss 85 is GRANTED in part and DENIED in part. Counts IV, V, and VII, as well as the p...
Entry #139 • 2016-05-24 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
SURREPLY to re Order, Set/Reset Deadlines, 85 MOTION to Dismiss Counts IV, V, VI and VII of Plaintiff Glycobiosciences' Amended Complaint Against Fidia Under Ru...
Entry #136 • 2016-05-16 Document →
Motion to Stay Pending IPR / Reexam Granted in Part
ORDER: Defendants' Motion to Stay Pending Outcome of Reexamination of Patent in Suit 114 is GRANTED in part. The stay applies to the patent infringement and con...
Entry #131 • 2016-05-02 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
REPLY to opposition to motion re 114 MOTION to Stay Pending Outcome of Reexamination of Patent in Suit filed by DARA BIOSCIENCES, INC., FIDIA FARMACEUTICI S.P.A...
Entry #124 • 2016-04-25 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
Memorandum in opposition to re 114 MOTION to Stay Pending Outcome of Reexamination of Patent in Suit filed by GLYCOBIOSCIENCES, INC.. (Attachments: # 1 Text of ...
Entry #120 • 2016-04-18 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
AFFIDAVIT re 120 Memorandum in Opposition (Declaration of Kevin Drizen in Opposition to Defendants' Motion to Stay Pending Reexamination of the Patent in Suit) ...
Entry #121 • 2016-04-18 Document →

Docket Entries

(296 total)
Pleading / Complaint

COMPLAINT GlycoBioSciences against All Defendants Innocutis and DARA BioSciences ( Filing fee $ 350 receipt number 0090-3140507) filed by GlycoBioSciences, Inc.. (Attachments: # 1 Exhibit Patent in Suit, # 2 Errata Patent in Suit, # 3 Civil Cover Sheet, # 4 USPTO Notice of Filing, # 5 Summons DARA, # 6 Summons Innocutis)(Zito, Joseph) (Entered: 11/25/2012)

Entry #1 • 2012-11-25
1
Pleading / Complaint

COMPLAINT GlycoBioSciences against All Defendants Innocutis and DARA BioSciences ( Filing fee $ 350 receipt number 0090-3140507) filed by GlycoBioSciences, Inc.. (Attachments: # 1 Exhibit Patent in Suit, # 2 Errata Patent in Suit, # 3 Civil Cover Sheet, # 4 USPTO Notice of Filing, # 5 Summons DARA, # 6 Summons Innocutis)(Zito, Joseph) (Entered: 11/25/2012)

Entry #1 • 2012-11-25
2
Pleading / Complaint

COMPLAINT GlycoBioSciences against All Defendants Innocutis and DARA BioSciences ( Filing fee $ 350 receipt number 0090-3140507) filed by GlycoBioSciences, Inc.. (Attachments: # 1 Exhibit Patent in Suit, # 2 Errata Patent in Suit, # 3 Civil Cover Sheet, # 4 USPTO Notice of Filing, # 5 Summons DARA, # 6 Summons Innocutis)(Zito, Joseph) (Entered: 11/25/2012)

Entry #1 • 2012-11-25
2
Pleading / Complaint

COMPLAINT GlycoBioSciences against All Defendants Innocutis and DARA BioSciences ( Filing fee $ 350 receipt number 0090-3140507) filed by GlycoBioSciences, Inc.. (Attachments: # 1 Exhibit Patent in Suit, # 2 Errata Patent in Suit, # 3 Civil Cover Sheet, # 4 USPTO Notice of Filing, # 5 Summons DARA, # 6 Summons Innocutis)(Zito, Joseph) (Entered: 11/25/2012)

Entry #1 • 2012-11-25
2
Pleading / Complaint

COMPLAINT GlycoBioSciences against All Defendants Innocutis and DARA BioSciences ( Filing fee $ 350 receipt number 0090-3140507) filed by GlycoBioSciences, Inc.. (Attachments: # 1 Exhibit Patent in Suit, # 2 Errata Patent in Suit, # 3 Civil Cover Sheet, # 4 USPTO Notice of Filing, # 5 Summons DARA, # 6 Summons Innocutis)(Zito, Joseph) (Entered: 11/25/2012)

Entry #1 • 2012-11-25
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc